APO RESEARCH · REPORT
Humira
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Product & engineering
Understand the product.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
Selected research
Market Structure
Global Humira Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Read the full market overview
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
This report provides an overview of the global Humira market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Humira and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Humira sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Humira market size, projected growth trends, production technologies, key applications, and end-use industries.
Humira Segment by Company
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Humira Segment by Type
Humira Syringe
Humira Pen
Humira Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Humira Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Humira market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Humira and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Humira.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Humira market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humira manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Humira in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Humira in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Humira Syringe
- Humira Pen
Applications
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Others
Companies covered
- AbbVie
- Eisai
- Cadila Healthcare
- Torrent Pharmaceuticals
- Amgen
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Humira Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Humira Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Humira Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Humira Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Humira Market Dynamics
- 2.1 Humira Industry Trends
- 2.2 Humira Industry Drivers
- 2.3 Humira Industry Opportunities and Challenges
- 2.4 Humira Industry Restraints
3 Humira Market by Manufacturers
- 3.1 Global Humira Revenue by Manufacturers (2021-2026)
- 3.2 Global Humira Sales by Manufacturers (2021-2026)
- 3.3 Global Humira Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Humira Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Humira Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Humira Manufacturers, Product Type & Application
- 3.7 Global Humira Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Humira Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Humira Players Market Share by Revenue in 2025
- 3.8.3 2025 Humira Tier 1, Tier 2, and Tier 3
4 Humira Market by Type
- 4.1 Humira Type Introduction
- 4.1.1 Humira Syringe
- 4.1.2 Humira Pen
- 4.2 Global Humira Sales by Type
- 4.2.1 Global Humira Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Humira Sales by Type (2021-2032)
- 4.2.3 Global Humira Sales Market Share by Type (2021-2032)
- 4.3 Global Humira Revenue by Type
- 4.3.1 Global Humira Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Humira Revenue by Type (2021-2032)
- 4.3.3 Global Humira Revenue Market Share by Type (2021-2032)
5 Humira Market by Application
- 5.1 Humira Application Introduction
- 5.1.1 Ankylosing Spondylitis
- 5.1.2 Rheumatoid Arthritis
- 5.1.3 Crohn’s Disease
- 5.1.4 Others
- 5.2 Global Humira Sales by Application
- 5.2.1 Global Humira Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Humira Sales by Application (2021-2032)
- 5.2.3 Global Humira Sales Market Share by Application (2021-2032)
- 5.3 Global Humira Revenue by Application
- 5.3.1 Global Humira Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Humira Revenue by Application (2021-2032)
- 5.3.3 Global Humira Revenue Market Share by Application (2021-2032)
6 Global Humira Sales by Region
- 6.1 Global Humira Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Humira Sales by Region (2021-2032)
- 6.2.1 Global Humira Sales by Region (2021-2026)
- 6.2.2 Global Humira Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Humira Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Humira Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Humira Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Humira Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Humira Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Humira Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Humira Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Humira Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Humira Revenue by Region
- 7.1 Global Humira Revenue by Region
- 7.1.1 Global Humira Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Humira Revenue by Region (2021-2026)
- 7.1.3 Global Humira Revenue by Region (2027-2032)
- 7.1.4 Global Humira Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Humira Revenue (2021-2032)
- 7.2.2 North America Humira Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Humira Revenue (2021-2032)
- 7.3.2 Europe Humira Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Humira Revenue (2021-2032)
- 7.4.2 Asia-Pacific Humira Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Humira Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Humira Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 AbbVie
- 8.1.1 AbbVie Company Information
- 8.1.2 AbbVie Business Overview
- 8.1.3 AbbVie Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 AbbVie Humira Product Portfolio
- 8.1.5 AbbVie Recent Developments
- 8.2 Eisai
- 8.2.1 Eisai Company Information
- 8.2.2 Eisai Business Overview
- 8.2.3 Eisai Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eisai Humira Product Portfolio
- 8.2.5 Eisai Recent Developments
- 8.3 Cadila Healthcare
- 8.3.1 Cadila Healthcare Company Information
- 8.3.2 Cadila Healthcare Business Overview
- 8.3.3 Cadila Healthcare Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cadila Healthcare Humira Product Portfolio
- 8.3.5 Cadila Healthcare Recent Developments
- 8.4 Torrent Pharmaceuticals
- 8.4.1 Torrent Pharmaceuticals Company Information
- 8.4.2 Torrent Pharmaceuticals Business Overview
- 8.4.3 Torrent Pharmaceuticals Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Torrent Pharmaceuticals Humira Product Portfolio
- 8.4.5 Torrent Pharmaceuticals Recent Developments
- 8.5 Amgen
- 8.5.1 Amgen Company Information
- 8.5.2 Amgen Business Overview
- 8.5.3 Amgen Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Amgen Humira Product Portfolio
- 8.5.5 Amgen Recent Developments
- 8.6 Boehringer Ingelheim
- 8.6.1 Boehringer Ingelheim Company Information
- 8.6.2 Boehringer Ingelheim Business Overview
- 8.6.3 Boehringer Ingelheim Humira Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Boehringer Ingelheim Humira Product Portfolio
- 8.6.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Humira Value Chain Analysis
- 9.1.1 Humira Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Humira Production Mode & Process
- 9.2 Humira Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Humira Distributors
- 9.2.3 Humira Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst